Classifications

• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
  • A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
  • A23L13/45—Addition of, or treatment with, microorganisms
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
  • C12N5/0068—General culture methods using substrates
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
  • C12N5/06—Animal cells or tissues; Human cells or tissues
  • C12N5/0602—Vertebrate cells
• • D—TEXTILES; PAPER
  • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
  • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
  • D01D5/00—Formation of filaments, threads, or the like
  • D01D5/0007—Electro-spinning
  • D01D5/0015—Electro-spinning characterised by the initial state of the material
  • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
  • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
• • D—TEXTILES; PAPER
  • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
  • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
  • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
  • D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
  • D01F6/92—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyesters
• • D—TEXTILES; PAPER
  • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
  • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
  • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
  • D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
  • D01F6/94—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of other polycondensation products
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N2533/00—Supports or coatings for cell culture, characterised by material
  • C12N2533/30—Synthetic polymers
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N2533/00—Supports or coatings for cell culture, characterised by material
  • C12N2533/50—Proteins

Definitions

• a cultured meat product may comprise a scaffold comprising an electrospun polymer fiber, and a population of cells.
• the cultured meat product may have, in some embodiments, a thickness from about 100 mm to about 500 mm.
• a method of producing such a cultured meat product may comprise preparing the scaffold, placing the scaffold into a bioreactor, adding the population of cells to the bioreactor, culturing the population of cells in the bioreactor containing the scaffold for a period of time, thereby forming the cultured meat product, and removing the cultured meat product from the bioreactor.
• the cultured meat product may be configured to mimic the taste, texture, size, shape, and/or topography of a traditional slaughtered meat.
• FIG. 1A shows an SEM image (8900x) of an embodiment of a scaffold as described herein, the scaffold electrospun using a 100k Mw PEO+zein solution.
• FIG. IB shows an SEM image (1700x) of the scaffold of FIG. 1A.
• FIG. 2A shows an SEM image (1500x) of an embodiment of a scaffold as described herein, the scaffold electrospun using a 1M Mw PEO+zein solution.
• FIG. 2B shows an SEM image (200x) of the scaffold of FIG. 2A.
• FIG. 3A shows an SEM image (5000x) of an embodiment of a scaffold as described herein, the scaffold electrospun using a PDLGA 5010+zein solution.
• FIG. 3B shows an SEM image (1650x) of the scaffold of FIG. 3A.
• FIG. 4A shows an SEM image (2150x) of an embodiment of a scaffold as described herein, the scaffold electrospun using a PCL+soy protein isolate solution.
• FIG. 4B shows an SEM image (215x) of the scaffold of FIG. 4 A.
• the term“consists of’ or“consisting of’ means that the device or method includes only the elements, steps, or ingredients specifically recited in the particular claimed embodiment or claim.
• traditional slaughtered meat means one or more types of meat obtained from a once-living animal for the purpose of consumption. Such meat is generally, although not always, obtained from livestock, fish, or other animals raised or slaughtered primarily for food production purposes.
• Non-limiting examples of traditional slaughtered meat include chicken, turkey, pork, steak, fish, and the like.
• Traditional slaughtered meat is generally appropriate for consumption by one or more mammal species.
• the term“cultured meat product” means a meat product that is produced by human or machine intervention, rather than grown as a natural component of a living animal. A cultured meat product is thus not obtained directly from the slaughter of a living animal. Like traditional slaughtered meat, a cultured meat product is generally appropriate for consumption by one or more mammal species.
• the cells in these cultures lack the necessary nutritional environment to properly stack on top of one another, although there are some cell lines that can potentially stack to form one or two additional layers in the presence of the correct signaling factors. Even so, it is implausible to expect a noticeable volume or thickness increase from traditional cell culture techniques, and this implausibility drastically affects the quality of and potential for cultured meat products. Companies currently developing these“clean” meat products tend to face similar engineering challenges.
• Electrospinning is a method which may be used to process a polymer solution into a fiber.
• the fiber may be referred to as a nanofiber.
• Fibers may be formed into a variety of shapes by using a range of receiving surfaces, such as mandrels or collectors.
• a flat shape such as a sheet or sheet-like fiber mold, a fiber scaffold and/or tube, or a tubular lattice, may be formed by using a substantially round or cylindrical mandrel.
• the electrospun fibers may be cut and/or unrolled from the mandrel as a fiber mold to form the sheet.
• the resulting fiber molds or shapes may be used in many applications, including filters and the like.
• Electrospinning methods may involve spinning a fiber from a polymer solution by applying a high DC voltage potential between a polymer injection system and a mandrel.
• one or more charges may be applied to one or more components of an electrospinning system.
• a charge may be applied to the mandrel, the polymer injection system, or combinations or portions thereof.
• the destabilized solution moves from the polymer injection system to the mandrel, its solvents may evaporate and the polymer may stretch, leaving a long, thin fiber that is deposited onto the mandrel.
• the polymer solution may form a Taylor cone as it is ejected from the polymer injection system and exposed to a charge.
• a first polymer solution comprising a first polymer and a second polymer solution comprising a second polymer may each be used in a separate polymer injection system at substantially the same time to produce one or more electrospun fibers comprising the first polymer interspersed with one or more electrospun fibers comprising the second polymer.
• Such a process may be referred to as“co-spinning” or“co electrospinning,” and a scaffold produced by such a process may be described as a co-spun or co-electrospun scaffold.
• a polymer injection system may include any system configured to eject some amount of a polymer solution into an atmosphere to permit the flow of the polymer solution from the injection system to the mandrel.
• the polymer injection system may deliver a continuous or linear stream with a controlled volumetric flow rate of a polymer solution to be formed into a fiber.
• the polymer injection system may deliver a variable stream of a polymer solution to be formed into a fiber.
• the polymer injection system may be configured to deliver intermittent streams of a polymer solution to be formed into multiple fibers.
• the polymer injection system may include a syringe under manual or automated control.
• the polymer injection system may include multiple syringes and multiple needles or needle-like components under individual or combined manual or automated control.
• a multi-syringe polymer injection system may include multiple syringes and multiple needles or needle-like components, with each syringe containing the same polymer solution.
• a multi-syringe polymer injection system may include multiple syringes and multiple needles or needle-like components, with each syringe containing a different polymer solution.
• a charge may be applied to the polymer injection system, or to a portion thereof. In some embodiments, a charge may be applied to a needle or needle-like component of the polymer injection system.
• the polymer solution may be ejected from the polymer injection system at a flow rate of less than or equal to about 5 mL/h per needle. In other embodiments, the polymer solution may be ejected from the polymer injection system at a flow rate per needle in a range from about 0.01 mL/h to about 50 mL/h.
• the flow rate at which the polymer solution is ejected from the polymer injection system per needle may be, in some non-limiting examples, about 0.01 mL/h, about 0.05 mL/h, about 0.1 mL/h, about 0.5 mL/h, about 1 mL/h, about 2 mL/h, about 3 mL/h, about 4 mL/h, about 5 mL/h, about 6 mL/h, about 7 mL/h, about 8 mL/h, about 9 mL/h, about 10 mL/h, about 11 mL/h, about 12 mL/h, about 13 mL/h, about 14 mL/h, about 15 mL/h, about 16 mL/h, about 17 mL/h, about 18 mL/h, about 19 mL/h, about 20 mL/h, about 21 mL/h, about 22 mL/h, about 23 mL/h, about 24
• the diameter of the resulting fibers may be in the range of about 100 nm to about 1500 nm.
• Some non-limiting examples of electrospun fiber diameters may include about 100 nm, about 150 nm, about 200 nm, about 250 nm, about 300 nm, about 350 nm, about 400 nm, about 450 nm, about 500 nm, about 550 nm, about 600 nm, about 650 nm, about 700 nm, about 750 nm, about 800 nm, about 850 nm, about 900 nm, about 950 nm, about 1,000 nm, about 1,050 nm, about 1,100 nm, about 1,150 nm, about 1,200 nm, about 1,250 nm, about 1,300 nm, about 1,350 nm, about 1,400 nm, about 1,450 nm, about 1,500 nm
• the polymer injection system may be filled with a polymer solution.
• the polymer solution may comprise one or more polymers.
• the polymer solution may be a fluid formed into a polymer liquid by the application of heat.
• a polymer solution may include, for example, non-resorbable polymers, resorbable polymers, natural polymers, or a combination thereof.
• the polymers may include, for example, nylon, nylon 6,6, polycaprolactone, polyethylene oxide terephthalate, polybutylene terephthalate, polyethylene oxide terephthalate-co-polybutylene terephthalate, polyethylene terephthalate, polyurethane, polyethylene, polyethylene oxide, polyvinylpyrrolidone, polymethylmethacrylate, polyacrylonitrile, silicone, polycarbonate, polylactide, polyglycolide, polyether ketone ketone, polyether ether ketone, polyether imide, polyamide, polystyrene, polyether sulfone, polysulfone, polyvinyl acetate, polytetrafluoroethylene, polyvinylidene fluoride, polylactic acid, polyglycolic acid, polylactide-co-glycolide, poly(lactide-co-caprolactone), polyglycerol sebacate, polydioxanone
• polymer solutions may also include a combination of one or more of non-resorbable, resorbable polymers, and naturally occurring polymers in any combination or compositional ratio.
• the polymer solutions may include a combination of two or more non-resorbable polymers, two or more resorbable polymers or two or more naturally occurring polymers.
• the polymer solution may comprise a weight percent ratio of, for example, from about 5% to about 90%. Non- limiting examples of such weight percent ratios may include about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, about 33%, about 35%, about
• the polymer solution may comprise one or more solvents.
• the solvent may comprise, for example, polyvinylpyrrolidone, hexafluoro-2-propanol (HFIP), acetone, dimethylformamide, dimethylsulfoxide, N- methylpyrrolidone, N,N-dimethylformamide, Nacetonitrile, hexanes, ether, dioxane, ethyl acetate, pyridine, toluene, xylene, tetrahydrofuran, trifluoroacetic acid, hexafluoroisopropanol, acetic acid, dimethylacetamide, chloroform, dichloromethane, water, alcohols, ionic compounds, or combinations thereof.
• HFIP hexafluoro-2-propanol
• the concentration range of polymer or polymers in solvent or solvents may be, without limitation, from about 1 wt % to about 50 wt %.
• Some non- limiting examples of polymer concentration in solution may include about 1 wt %, 3 wt %, 5 wt %, about 10 wt %, about 15 wt %, about 20 wt %, about 25 wt %, about 30 wt %, about 35 wt %, about 40 wt %, about 45 wt %, about 50 wt %, or ranges between any two of these values, including endpoints.
• the polymer solution may also include additional materials.
• additional materials may include fluorescent materials, luminescent materials, antibiotics, growth factors, vitamins, cytokines, steroids, anti inflammatory drugs, small molecules, sugars, salts, peptides, proteins, cell factors, DNA, RNA, fats, proteins, carbohydrates, minerals, or any combination thereof.
• the additional material may have nutritional value.
• the additional materials may be present in the polymer solution or in the resulting electrospun polymer fibers in an amount from about 1 wt % to about 1500 wt % of the polymer mass. In some non-limiting examples, the additional materials may be present in the polymer solution or in the resulting electrospun polymer fibers in an amount of about 1 wt %, about 5 wt %, about 10 wt %, about 15 wt %, about 20 wt %, about 25 wt %, about 30 wt %, about 35 wt %, about 40 wt %, about 45 wt %, about 50 wt %, about 55 wt %, about 60 wt %, about 65 wt %, about 70 wt %, about 75 wt %, about 80 wt %, about 85 wt %, about 90 wt %, about 95 wt %, about 100 w
• one or more charges may be applied to one or more components, or portions of components, such as, for example, a mandrel or a polymer injection system, or portions thereof.
• a positive charge may be applied to the polymer injection system, or portions thereof.
• a negative charge may be applied to the polymer injection system, or portions thereof.
• the polymer injection system, or portions thereof may be grounded.
• a positive charge may be applied to mandrel, or portions thereof.
• a negative charge may be applied to the mandrel, or portions thereof.
• the mandrel, or portions thereof may be grounded.
• one or more components or portions thereof may receive the same charge.
• one or more components, or portions thereof may receive one or more different charges.
• the charge applied to any component of the electrospinning system, or portions thereof may be from about -15kV to about 30kV, including endpoints.
• the charge applied to any component of the electrospinning system, or portions thereof may be about -15kV, about -10kV, about -5kV, about -4kV, about -3kV, about -1kV, about -0.01kV, about 0.01kV, about 1kV, about 5kV, about 10kV, about 11kV, about 11.1 kV, about 12kV, about 15kV, about 20kV, about 25kV, about 30kV, or any range between any two of these values, including endpoints.
• any component of the electrospinning system, or portions thereof may be grounded.
• the mandrel may move with respect to the polymer injection system.
• the polymer injection system may move with respect to the mandrel.
• the movement of one electrospinning component with respect to another electrospinning component may be, for example, substantially rotational, substantially translational, or any combination thereof.
• one or more components of the electrospinning system may move under manual control.
• one or more components of the electrospinning system may move under automated control.
• the mandrel may be in contact with or mounted upon a support structure that may be moved using one or more motors or motion control systems.
• the pattern of the electrospun fiber deposited on the mandrel may depend upon the one or more motions of the mandrel with respect to the polymer injection system.
• the mandrel surface may be configured to rotate about its long axis.
• a mandrel having a rotation rate about its long axis that is faster than a translation rate along a linear axis may result in a nearly helical deposition of an electrospun fiber, forming windings about the mandrel.
• a mandrel having a translation rate along a linear axis that is faster than a rotation rate about a rotational axis may result in a roughly linear deposition of an electrospun fiber along a liner extent of the mandrel.
• Scaffolds of various sizes and thicknesses may help solve the engineering problems that cultured meat products currently face.
• using a cellular engineering process that involves cells and such a scaffold may allow for the migration of the cells throughout the entirety of the scaffold.
• many existing scaffolds fail to provide the correct representation of the extracellular matrix.
• Electrospun polymer fibers may provide solutions to these challenges. Electrospun polymer fibers may be used to create scaffolds of various sizes and thicknesses. In contrast to scaffolds made from other materials, electrospun polymer fibers may be formed into a variety of shapes, including discs, tubes, sheets, and the like, making them easy to fit into existing cell culture devices. The use of electrospun polymer fiber scaffolds may allow the creation of a higher volume of cultured meat using existing equipment. Moreover, electrospun fiber scaffolds could be used to develop products with specific structures (including meats like steaks or sashimi, for example), targeting a specific volume and cellular environment for the final product.
• specific structures including meats like steaks or sashimi, for example
• Electrospun polymer fibers can be used, for example, to create a scaffold having highly aligned fibers. Such aligned fibers may provide the necessary topographical and electrical cues to cells in culture, providing appropriate stimulation for the development of engineered musculoskeletal tissue.
• Lactic acid is produced in two instances: in times of high stress, and during anaerobic respiration. Research has suggested that post-mortem, muscle cells continue to operate for a short period of time from anaerobic respiration. The lactic acid produced during that period is thought to drop the pH of the meat to around 5.5, although a wider range of pH values may be found in different meats. Electrospun polymer fibers can be engineered to specifically deteriorate or dissolve over a period of time into chemical byproducts naturally found in the body, including lactic acid, glycolic acid, and caproic acid.
• the period of time can range depending on the planned end product, and can be anywhere from about 1 day to about 6 weeks.
• the dissolution of electrospun polymer fibers into these chemical byproducts may create a more acidic environment that would lead to an improved cultured meat product.
• a small drop in the pH of the cell environment may also encourage healthy, organized tissue growth. Accordingly, a decrease in pH during culturing could lead to improved tissue growth (and thereby improved texture), as well as improved taste of the cultured meat product.
• electrospun polymer fibers may be made from various different polymers, as described above, and these different polymers may be used to promote different cell differentiation and/or proliferation properties for different components of cultured meat, including myocytes, adipocytes, and chondrocytes in muscle, fat, and connective tissue, respectively. These different tissue types differentiate stem cells in their own unique ways based on different environmental and/or chemical signals. Electrospun polymer fibers could be used to create a scaffold having different sections with different properties, each section designed to generate and support a desired tissue type. Electrospun polymer fibers can be manufactured with different moduli, diameters, surface textures, surface chemical interactions, or spatially controlled drug delivery systems. In short, electrospun polymer fibers could be used to create cultured meat products that look, feel, and taste like traditional slaughtered meats.
• the cultured meat products described herein may comprise a scaffold and a population of cells.
• the population of cells may include, in some non limiting examples, mesenchymal stem cells, myocytes, adipocytes, chondrocytes, osteoblasts, or any combination thereof.
• Publications that demonstrate the culture of myocytes, adipocytes chondrocytes, and osteoblasts on electrospun polymer fibers include: (1) Khan et al. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch. PLOS One. 2015;10(5):e0126338.
• the scaffold may comprise an electrospun polymer fiber as described herein.
• the electrospun polymer fiber may comprise a polymer selected from nylon, nylon 6,6, polycaprolactone, polyethylene oxide terephthalate, polybutylene terephthalate, polyethylene oxide terephthalate-co-polybutylene terephthalate, polyethylene terephthalate, polyurethane, polyethylene, polyethylene oxide, polyvinylpyrrolidone, polymethylmethacrylate, polyacrylonitrile, silicone, polycarbonate, polylactide, polyglycolide, polyether ketone ketone, polyether ether ketone, polyether imide, polyamide, polystyrene, polyether sulfone, polysulfone, polyvinyl acetate, polytetrafluoroethylene, polyvinylidene fluoride, polylactic acid, polyglycolic acid, polylactide-co-glycolide, poly(lactide-co
• the electrospun polymer fiber may comprise multiple electrospun polymer fibers aligned substantially parallel to one another, as described herein.
• the electrospun fiber may comprise multiple electrospun polymer fibers having different orientations relative to one another, including randomly oriented, substantially parallel, and combinations thereof, as described herein.
• the multiple electrospun polymer fibers may have multiple orientations and/or multiple fiber diameters, as described herein, and may comprise one or more polymers, as described herein.
• a scaffold may comprise multiple co-spun electrospun polymer fibers, as described herein.
• the scaffold may further comprise one or more electrospun polymer fiber fragments.
• the electrospun polymer fiber fragments may be, for example, dispersed throughout the scaffold, or dispersed throughout a particular portion of the scaffold. Without wishing to be bound by theory, the electrospun polymer fiber fragments may aid or support the culturing and expansion of cells within the scaffold.
• the electrospun polymer fiber fragments may have a length from about 100 mm to about 10 mm. In certain embodiments, the electrospun polymer fiber fragments may have a maximum length of about 1 mm.
• the scaffold may comprise one or more electrospun polymer fiber types, and the one or more electrospun polymer fiber types may be co-spun.
• each electrospun fiber type may be suitable to support the differentiation of one or more cells into a different biological tissue.
• a scaffold may comprise a first electrospun polymer fiber type suitable to support the differentiation of cells into muscle, a second electrospun polymer fiber type suitable to support the differentiation of cells into bone, a third electrospun polymer fiber type suitable to support the differentiation of cells into cartilage, a fourth electrospun polymer fiber type suitable to support the differentiation of cells into a connective tissue, a fifth electrospun polymer fiber type suitable to support the differentiation of cells into a blood vessel, or any combination of these electrospun polymer fiber types.
• a scaffold may include, in one non-limiting example, a first plurality of electrospun polymer fibers comprising a polymer and having a diameter and/or orientation to support the proliferation of a first type of cells; a second plurality of electrospun polymer fibers comprising a polymer and having a diameter and/or orientation to support the proliferation of a second type of cells; a third plurality of electrospun polymer fibers comprising a polymer and having a diameter and/or orientation to support the proliferation of a third type of cells; a fourth plurality of electrospun polymer fibers comprising a polymer and having a diameter and/or orientation to support the proliferation of a fourth type of cells; and so on.
• the first, second, third, and fourth types of cells in such embodiments may include any mammalian cells, such as muscle cells, vascular cells, fat cells, connective tissue cells, neural cells, or combinations thereof.
• the electrospun polymer fiber may comprise a polymer configured to degrade to produce a byproduct.
• the byproduct may include, for example, lactic acid, glycolic acid, caproic acid, and combinations thereof.
• the electrospun polymer fiber may be configured to degrade upon exposure to a substance; in one non-limiting example, the substance may comprise saliva.
• the electrospun polymer fiber may comprise an additional material, as described herein, and may be configured to release at least a portion of the additional material upon the application of a mechanical force.
• the mechanical force may be produce by actions such as chewing, cutting, breaking, or combinations thereof.
• the cultured meat product may include an intact electrospun polymer fiber, while in other embodiments, the electrospun polymer fiber of the scaffold may be completely or nearly completely resorbed in the final cultured meat product.
• the intact electrospun polymer fiber may be configured to mimic the texture and/or other properties of traditional slaughtered meat.
• the cultured meat product may have a thickness from about 100 mm to about 500 mm.
• the thickness may be, for example, about 100 mm, about 200 mm, about 300 mm, about 400 mm, about 500 mm, about 600 mm, about 700 mm, about 800 mm, about 900 mm, about 1 mm, about 5 mm, about 10 mm, about 25 mm, about 50 mm, about 75 mm, about 100 mm, about 125 mm, about 150 mm, about 175 mm, about 200 mm, about 225 mm, about 250 mm, about 275 mm, about 300 mm, about 325 mm, about 350 mm, about 375 mm, about 400 mm, about 425 mm, about 450 mm, about 475 mm, about 500 mm, or any range between any two of these values, including endpoints.
• the cultured meat product may have a thickness from about 5 mm to about 75 mm. In an embodiment, the thickness
• the cultured meat products described herein may be configured to mimic or closely resemble a property of a traditional slaughtered meat.
• the property may include, for example, taste, texture, size, shape, topography, or any combination thereof.
• a method of producing a cultured meat product may comprise preparing a scaffold as described herein, placing the scaffold into a bioreactor, adding a population of cells to the bioreactor, culturing the population of cells in the bioreactor containing the scaffold for a period of time, thereby forming the cultured meat product, and removing the cultured meat product from the bioreactor.
• the cultured meat product may have the characteristics and features of the cultured meat products described herein.
• the scaffold and population of cells may each have the characteristics and features of the scaffolds and populations of cells described herein.
• the step of culturing the population of cells in the bioreactor may be carried out for a period of time.
• the period of time could be, for example, about 1 day, about 2 days, about 3 days, about 4 days, about 5 days, about 6 days, about 1 week, about 1.5 weeks, about 2 weeks, about 2.5 weeks, about 3 weeks, about 3.5 weeks, about 4 weeks, about 4.5 weeks, about 5 weeks, about 5.5 weeks, about 6 weeks, or any range between any two of these values, including endpoints.
• the period of time may be about 3 weeks.
• Example 1 Zein-containing scaffolds for cultured meat products
• Electrospun zein as a plant-based protein component of a scaffold was investigated for inclusion in a cultured meat product, as described herein. 90% ethanol in distilled water quickly dissolved zein powder. This 90%aqEtOH solution was able to produce zein fibers with electrospinning, but the electrospinning process was not sufficiently stable for zein-only fibers.
• FIG. 1A shows an SEM image (8900x) of a scaffold electrospun using a 100k Mw PEO+zein solution, as described above, and FIG. 1B shows an SEM image (1700x) of the scaffold of FIG. 1A.
• FIG. 1A and FIG. IB both show relatively cylindrical fibers, as described above.
• FIG. 2A shows an SEM image (1500x) of a scaffold electrospun using a 1M Mw PEO+zein solution, as described above
• FIG. 2B shows an SEM image (200x) of the scaffold of FIG. 2A.
• FIG. 2A and FIG. 2B both show ribbon-like fibers, as described above.
• FIG. 3 A shows an SEM image (5000x) of a scaffold electrospun using a PDLGA 5010+zein solution, as described above.
• FIG. 3B shows an SEM image (1650x) of the scaffold of FIG. 3A.
• FIG. 3A and FIG. 3B both show ribbon-like fibers.
• the addition of zein to electrospun polymer fibers may accelerate the rate of cellular growth when a scaffold comprising such fibers is used to culture cells for meat products.
• the cultured cells do not entirely consume the zein within the scaffold the zein is a plant- based protein that is safe for consumption.
• Soy protein isolate was added to a polycaprolactone (PCL) solution at 50% of the mass of the PCL to create electrospun polymer fibers having about 33% of the final dry mass from soy protein isolate and about 67% of the final dry mass from PCL.
• PCL polycaprolactone
• This combination produced a sheet of material with substantial mechanical integrity.
• the resulting average fiber diameter was about 6.5 mm, and the soy protein isolate appeared to be a significant part of the fibers. While large agglomerates of the soy protein isolates appeared, they appeared to be incorporated into a fiber or a fiber-like structure. The resulting fibers also appeared to maintain a fair degree of porosity.
• FIG. 4A shows an SEM image (2150x) of a scaffold electrospun using a PCL+soy protein isolate solution, as described above.
• FIG. 4B shows an SEM image (215x) of the scaffold of FIG. 4A.

Landscapes

• Engineering & Computer Science (AREA)
• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Biomedical Technology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Organic Chemistry (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Genetics & Genomics (AREA)
• Biotechnology (AREA)
• Microbiology (AREA)
• Polymers & Plastics (AREA)
• Food Science & Technology (AREA)
• Nutrition Science (AREA)
• Cell Biology (AREA)
• Biochemistry (AREA)
• General Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Textile Engineering (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Dispersion Chemistry (AREA)
• Mechanical Engineering (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Apparatus Associated With Microorganisms And Enzymes (AREA)
• Meat, Egg Or Seafood Products (AREA)
• Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
• Nonwoven Fabrics (AREA)

Priority Applications (8)

Applications Claiming Priority (2)

Publications (1)

Family

ID=71836937

Family Applications (1)

Country Status (9)

Cited By (4)

Families Citing this family (7)

Citations (3)

Family Cites Families (5)

• 2020
  • 2020-02-03 EP EP20747880.1A patent/EP3918117A4/en not_active Withdrawn
  • 2020-02-03 AU AU2020216496A patent/AU2020216496A1/en not_active Abandoned
  • 2020-02-03 SG SG11202108167RA patent/SG11202108167RA/en unknown
  • 2020-02-03 JP JP2021544479A patent/JP2022523724A/ja active Pending
  • 2020-02-03 WO PCT/US2020/016368 patent/WO2020160533A1/en not_active Ceased
  • 2020-02-03 BR BR112021012871A patent/BR112021012871A8/pt not_active Application Discontinuation
  • 2020-02-03 CA CA3127370A patent/CA3127370A1/en active Pending
  • 2020-02-03 US US16/780,187 patent/US20200245658A1/en not_active Abandoned
  • 2020-02-03 IL IL316394A patent/IL316394A/en unknown
• 2021
  • 2021-07-19 IL IL284948A patent/IL284948A/en unknown
• 2023
  • 2023-10-03 US US18/479,870 patent/US20240284947A1/en active Pending

Patent Citations (3)

Non-Patent Citations (3)

Also Published As

Similar Documents

Legal Events